Funder
The University of North Carolina at Chapel Hill
National Institutes of Health
University of North Carolina
National Institute of General Medical Sciences
Reference47 articles.
1. Molecular targeted therapy of cancer: The progress and future prospect;Ke;Front. Lab. Med.,2017
2. Antibodies to watch in 2021;Kaplon,2021
3. Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations;Gilad;Cancers,2021
4. Intratumor heterogeneity: the rosetta stone of therapy resistance;Marusyk;Cancer Cell,2020
5. Investigating the Evolutionary Dynamics of Drug Resistance in Colorectal Cancer Doctor of Philosophy;Whiting,2021